Skip to content
Lower risk Medical device recall · FDA · Published April 7, 2020

Inpeco Accelerator a3600 System Recall: Interface Module Communication Error

Inpeco recalls Accelerator a3600 Automation System with specific interface modules due to a communication error causing sample tube misassociation. Affected units may require correction to prevent sample handling errors.

🇺🇸 FDA recall #Z-2141-2020Medical deviceInpeco ›
Take action

Contact the company

Recalling firmInpeco S.A.Via San Gottardo 10 · Lugano, Switzerland
✎ GovInfoNow plain-language explainer

Inpeco is recalling certain Accelerator a3600 Automation System interface modules because a communication error can cause sample tubes to be misassociated with carriers. This could lead to incorrect lab results if the system is used without correction. Read more at govinfonow.com/recall/65470-inpeco-accelerator-a3600-system-recall-interface-module-communication-error.

Source Summary by GovInfoNow · govinfonow.com/recall/65470-inpeco-accelerator-a3600-system-recall-interface-module-communication-error · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2141-2020

Cite this page

“Inpeco Accelerator a3600 System Recall: Interface Module Communication Error.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/65470-inpeco-accelerator-a3600-system-recall-interface-module-communication-error. Based on FDA recall #Z-2141-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2141-2020%22&limit=1).

Inpeco S.A. voluntarily recalled three Accelerator a3600 Automation Systems on April 7, 2020, according to the FDA. The recall addresses a communication error that can cause erroneous sample associations. The agency announced the Class II device recall.

How to tell if you have it

  • Brand: Inpeco
  • Product: Accelerator a3600 Automation System with Advia2120LAS Interface Module (P/N FLX-219-00, FLX-219-10), ImmunoCAP 1000 Interface Module (P/N FLX-226-01, FLX-226-10), or StaRRsed Interface Module (P/N FLX-268-00)
  • Serial Numbers: ACP.290, ACP.343, ACP.365
  • Units affected: 3 systems

The hazard

The hazard is an erroneous association between the carrier and the sample tube caused by a communication error between the firmware of the Interface Modules and the Automation software. This problem occurs when one of these Interface Modules is put off-line after a carrier in their secondary lane is physically returned on the main track and then put back on-line when the carrier is used to transport another tube.

Context

GovInfoNow's records show Inpeco S.A. has 13 other recalls on record since 2025-10-30. Other recent recalls of similar products include Inpeco FlexLab FLX-217-40 (2025-10-30), Inpeco FlexLab X Potassium Test System (2025-09-03), and Roche Cobas 8000 Interface Module (2023-11-03).

How to tell if you have this one

Check for the specific interface modules: Advia2120LAS (P/N FLX-219-00, FLX-219-10), ImmunoCAP 1000 (P/N FLX-226-01, FLX-226-10), or StaRRsed (P/N FLX-268-00). Units with serial numbers ACP.290, ACP.343, or ACP.365 are affected.

  • Brand
    Inpeco
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    US Nationwide including in the states of IL, NY.
Recall numberProduct, codes & lotsQuantity
Z-2140-2020FlexLab Automation System with Advia2120LAS Interface Module (P/N FLX-219-00, FLX-219-10), ImmunoCAP 1000 Interface Module (P/N FLX-226-01, FLX-226-10), or StaRRsed Interface Module (P/N FLX-268-00)is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The systems consolidate multiple Analytical instruments into a unified workstation.; Serial Numbers: FLX.005 FLX.006 FLX.011 FLX.0117 FLX.0121 FLX.0124 FLX.0126 FLX.0129 FLX.0133 FLX.0136 FLX.0139 FLX.0140 FLX.0147 FLX.0149 FLX.0153 FLX.0157 FLX.016 FLX.0165 FLX.0168 FLX.0173 FLX.0189 FLX.0191 FLX.0192 FLX.022 FLX.030 FLX.032 FLX.035 FLX.036 FLX.037 FLX.050 FLX.056 FLX.060 FLX.062 FLX.065 FLX.082 FLX.096 SHD.00237 systems
Z-2141-2020Accelerator a3600 Automation System with Advia2120LAS Interface Module (P/N FLX-219-00, FLX-219-10), ImmunoCAP 1000 Interface Module (P/N FLX-226-01, FLX-226-10), or StaRRsed Interface Module (P/N FLX-268-00) is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The systems consolidate multiple Analytical instruments into a unified workstation.; Serial Numbers: ACP.290 ACP.343 ACP.3653 systems
Z-2142-2020Aptio Automation System with Advia2120LAS Interface Module (P/N FLX-219-00, FLX-219-10), ImmunoCAP 1000 Interface Module (P/N FLX-226-01, FLX-226-10), or StaRRsed Interface Module (P/N FLX-268-00) - Product Usage: is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The systems consolidate multiple Analytical instruments into a unified workstation.; Serial Numbers: AP2.0003 AP2.0007 AP2.0008 AP2.0009 AP2.0010 AP2.0017 AP2.0022 AP2.0025 AP2.0036 AP2.0049 AP2.0052 AP2.0057 AP2.0058 AP2.0059 AP2.0064 AP2.0065 AP2.0077 AP2.0082 AP2.0083 AP2.0089 AP2.0090 AP2.0092 AP2.0098 AP2.0100 AP2.0105 AP2.0109 AP2.0110 AP2.0129 AP2.0136 AP2.0149 AP2.0156 AP2.0173 AP2.0179 AP2.0180 AP2.0181 AP2.0193 AP2.0194 AP2.0201 AP2.0202 AP2.0211 AP2.0230 AP2.0233 AP2.0235 AP2.0236 AP2.0238 AP2.0251 AP2.0254 AP2.0258 AP2.0264 AP2.0269 AP2.0270 AP2.0275 AP2.0289 AP2.0295 AP2.0317 AP2.0325 AP2.0332 AP2.0339 AP2.0375 AP2.0381 AP2.0394 AP2.0411 AP2.0427 APT.0009 APT.0014 APT.0058 APT.0065 APT.0091 APT.0136 APT.024770 systems
Based on the official FDA remedy

What to do — step by step

  1. Check Module Serial Numbers

    Identify the serial numbers of your interface modules to confirm if they match the affected units listed (ACP.290, ACP.343, ACP.365).

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 2 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: nationwideMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: nationwideTXFlorida: nationwideFL

FDA distribution: “US Nationwide including in the states of IL, NY.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Illinois, New York.

Recall timeline

FDA terminated this recall 3.8 years after the firm started it.

1. Firm started the recall: Apr 7, 202012. FDA classified it Class II: May 28, 202023. Published in FDA’s Enforcement Report: Jun 3, 202034. FDA terminated the recall: Feb 6, 2024420202024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2141-2020 (April 7, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2141-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA